- Open Access
Literature information in PubChem: associations between PubChem records and scientific articles
© US Government 2016
Received: 15 February 2016
Accepted: 24 May 2016
Published: 10 June 2016
PubChem is an open archive consisting of a set of three primary public databases (BioAssay, Compound, and Substance). It contains information on a broad range of chemical entities, including small molecules, lipids, carbohydrates, and (chemically modified) amino acid and nucleic acid sequences (including siRNA and miRNA). Currently (as of Nov. 2015), PubChem contains more than 150 million depositor-provided chemical substance descriptions, 60 million unique chemical structures, and 225 million biological activity test results provided from over 1 million biological assay records.
Many PubChem records (substances, compounds, and assays) include depositor-provided cross-references to scientific articles in PubMed. Some PubChem contributors provide bioactivity data extracted from scientific articles. Literature-derived bioactivity data complement high-throughput screening (HTS) data from the concluded NIH Molecular Libraries Program and other HTS projects. Some journals provide PubChem with information on chemicals that appear in their newly published articles, enabling concurrent publication of scientific articles in journals and associated data in public databases. In addition, PubChem links records to PubMed articles indexed with the Medical Subject Heading (MeSH) controlled vocabulary thesaurus.
Literature information, both provided by depositors and derived from MeSH annotations, can be accessed using PubChem’s web interfaces, enabling users to explore information available in literature related to PubChem records beyond typical web search results.
PubChem (https://pubchem.ncbi.nlm.nih.gov) [1–6] is an open archive which contains information on a broad range of chemical entities, including small molecules, lipids, carbohydrates, and (chemically modified) amino acid and nucleic acid sequences (including siRNA and miRNA). Since it was launched in 2004 as a component of the Molecular Libraries Program (MLP) of the U.S. National Institutes of Health (NIH), PubChem has been serving as a chemical information resource for scientific communities in many areas including chemical biology, cheminformatics, and medicinal chemistry.
Data organization in PubChem is described in detail elsewhere [6, 7], and only a brief summary is given here. Chemical information contained in PubChem is deposited by more than 350 data contributors including government agencies, academic institutions, pharmaceutical companies, chemical vendors, and publishers. PubChem organizes this information into three primary databases: Substance, Compound, and BioAssay. The Substance database (https://www.ncbi.nlm.nih.gov/pcsubstance) archives depositor-provided chemical substance descriptions. The Compound database (https://www.ncbi.nlm.nih.gov/pccompound) stores unique chemical structures extracted from the Substance database through a standardization process. The BioAssay database (https://www.ncbi.nlm.nih.gov/pcassay) contains descriptions and results of biological assay experiments. The record accessions used for the respective PubChem databases are the Substance ID (SID), Compound ID (CID) and Assay ID (AID).
As of November 2015, PubChem contains more than 150 million depositor-provided substance descriptions, 60 million unique chemical structures, and 225 million biological activity test results (from over 1 million assay experiments performed on more than 2 million small-molecules covering almost 10,000 unique protein target sequences that correspond to more than 5000 genes). It also contains RNA interference (RNAi) screening assays that target over 15,000 genes. Many of these PubChem records (substances, compounds, and assays) have depositor-provided cross-references to scientific articles in PubMed (https://www.pubmed.gov) [8–11], a biomedical literature search system developed and maintained by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM), an institute within NIH.
PubMed, whose primary identifier is the PubMed ID (PMID), provides free access to more than 25 million scientific abstracts covering the fields of medicine, nursing, dentistry, veterinary medicine, health care systems, and preclinical sciences. Nearly 90 % of the PubMed contents are from MEDLINE [11, 12], which is the NLM’s bibliographic database containing more than 22 million abstracts of journal articles in life sciences with a concentration in biomedicine. A distinctive feature of MEDLINE is that the records are “indexed” with Medical Subject Headings (MeSH) [13, 14]. MeSH is the NLM’s controlled vocabulary thesaurus, consisting of sets of terms naming descriptors in a hierarchical structure. Indexing of scientific papers with MeSH terms enables users to perform a literature search at various levels of specificity. Of keen interest to PubChem is that MeSH includes a large number of chemical substance concepts, chemical names associated with each concept, and specific/qualified links between these concepts and PMIDs. Considering PubChem contains many chemical names, MeSH allows PubChem records to be linked to the biomedical literature using matching chemical names.
There are multiple sources of links to PubMed articles within PubChem and different contexts where they can be specified within a given PubChem record type. Understanding where these links can be provided and who provides them can help aid in their use. For example, they can provide PubChem users quick access to the original source article of a bioactivity result. In some cases, data contributors provide chemical information extracted from the scientific literature through manual curation or data mining. In addition, PubChem performs an automated process that annotates PubChem records with MeSH terms (by means of chemical name matching), creating associations between PubChem records and PubMed articles that share the same MeSH annotation. This work summarizes the various sources of PubMed links in PubChem, explains ways to access these links, and examines the scope of literature information associated with PubChem records.
Construction and content
Depositor-provided cross-references to scientific articles
Cross-references from substances/compounds to PubMed articles
Summary of depositor-provided cross-references to PubMed articles from PubChem substances and compounds
Number of cross-references
Number of records involved
IBM Almaden Research Centera
Comparative toxicogenomics databaseb
IUPHAR/BPS guide to PHARMACOLOGYd
Human metabolome databasee
Immune epitope database (IEDB)f
Biocatalysis/biodegradation database (BBD)i
Bioinformatics and drug design (BIDD) groupj
The biggest source of SID-PMID cross-references is the IBM Almaden Research Center (http://www.research.ibm.com/labs/almaden/index.shtml). This PubChem depositor provides PMIDs of the scientific articles mentioning a particular chemical. While beyond the scope of this paper, they also provide links to patent documents mentioning a particular chemical. The IBM substance records provide more than 90 % of the SID-PMID cross-references involving about half of all substance records containing cross-references to PubMed articles.
The next largest sources of depositor-provided literature links for PubChem Substance and Compound records are ChemDB [http://chemdb.niaid.nih.gov/—provided by the U.S. National Institute of Allergy and Infectious Diseases (NIAID)] and the Comparative Toxicogenomics Database (CTD) (http://ctdbase.org/) , which provide 144 thousand cross-references for 114 thousand substances and 226 thousand cross-references for 14 thousand substances, respectively. Other notable contributors for biologically relevant SID-PMID cross-references include IUPHAR/BPS Guide to Pharmacology (http://www.guidetopharmacology.org) , Human Metabolome Database (HMDB) (http://www.hmdb.ca/) , Immune Epitope Database (IEDB) (http://www.iedb.org/) , BioCyc (http://biocyc.org/) , DrugBank (http://www.drugbank.ca/) , and the Biocatalysis/Biodegradation database (BBD) (http://eawag-bbd.ethz.ch/) .
The disproportionate number of cross-references and chemical substance coverage coming from a handful of data contributors (Table 1) points to their diverging focus areas in data collection. For example, IBM uses data mining to collect information on patents and scientific papers that mention a very broad range of chemicals, resulting in a large number of links to scientific papers. On the other hand, DrugBank primarily focuses on U.S. Food and Drug Administration (FDA) drugs (approved and experimental) and collects relevant information through manual curation. Similarly, the IEDB resource performs manual curation but considers chemical substances in the immunology epitope research domain. As such, PMID cross-references provided by different chemical substance data depositors can have a significantly varied focus and approach.
Bioactivity data extracted from scientific articles
Summary of cross-references from literature-extracted bioassay data to PubMed articles
IUPHAR/BPS guide to pharmacologyc
ChEMBL (https://www.ebi.ac.uk/chembl/)  is a public database of bioactivity information for compounds. Most of the bioactivity data contained in ChEMBL is manually extracted from the full text of peer-reviewed scientific papers published in about 50 journals in the medicinal chemistry and natural product domains. From each paper, detailed information is extracted on the compounds tested, the assays performed, and the targets for the assays. Often multiple data sets are generated for a single paper, resulting in multiple BioAssay records for that publication. The ChEMBL data is updated on a regular basis, with periodic releases approximately every 3–6 months. The current version of ChEMBL (ChEMBL v20, as of September 2015) contains 13 million bioactivities for 1.5 million unique compounds, abstracted from about 60 thousand publications or provided by other data sources. ChEMBL contributes its literature-derived data to the PubChem BioAssay database.
The Guide to Pharmacology (http://www.guidetopharmacology.org) , created under the auspices of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the British Pharmacological Society (BPS), provides in-depth integrated views of the pharmacology, genetics, functions, and pathophysiology of important drug targets, including G-protein-coupled receptors (GPCRs), ion channels, and nuclear hormone receptors (NHRs). In addition, it provides information on the interactions between these target proteins and their ligands. PubMed citations containing the bioactivity data for these ligands are also provided to PubChem.
The PDBbind database (http://www.pdbbind-cn.org)  collects experimentally measured binding affinity data (IC50, Kd, or Ki) for biomolecular complexes in the Protein Data Bank (PDB) . The majority of the data in PDBbind is for complexes between proteins and small molecule ligands, although it also contains other types of complexes such as protein–protein, protein–nucleic acid, and nucleic acid–ligand complexes. All binding affinity data in PDBbind are manually curated from nearly 24,000 original references. PDBbind contributes to PubChem binding affinity data for ~10,000 protein–ligand complexes that involve ~3000 unique small molecule chemical structures, with related information including the PMID for the source article, PDB ID and MMDB ID  for the protein–ligand structures, and the protein GI and name for the protein target.
BindingDB (https://www.bindingdb.org)  provides measured binding affinities, focusing chiefly on the interactions of proteins considered to be drug targets with small, drug-like molecules. BindingDB contains more than one million binding interactions for seven thousand protein targets and 495 thousand small molecules.
GLIDA (GPCR-Ligand Database) (http://pharminfo.pharm.kyoto-u.ac.jp/services/glida/)  is a public chemical genomics database that provides information on GPCRs, their ligands, and interactions between them. The ligand-binding information was manually collected and curated from PubMed and other sources. Although GLIDA has ceased updates since 2010, it is still operational and its data are fully accessible.
In addition to these resources containing manually curated sources of bioactivity, there is a growing number of AID-PMID references deposited directly by the authors of scientific publications uploading their research data into the PubChem BioAssay database. This includes researchers from RNAi screening and is open to all researchers in the chemical biology, medicinal chemistry, and related fields. Such submissions help to satisfy open access and data sharing requirements from research funding agencies.
Note that different PubChem BioAssay data sources can provide PubMed links in different ways. For example, ChEMBL provides the cross-reference between an assay and the article from which bioactivity information for that assay were extracted, and therefore, literature evidence on bioactivity data for substances tested in that assay can be deduced from the AID-PMID cross-reference. PDBbind provides information on the source article of bioactivity data for each substance tested in an assay (as a property of the tested substance reported in the assay data table). GLIDA does not explicitly provide literature information for assays or tested substances in them. Instead, it provides the GLIDA ID (the database identifier used in GLIDA) for a substance. This external ID is used to search for the corresponding record in GLIDA to get information on the source article.
Chemical information provided by journal publishers
Publishers are also an indirect source of records in PubChem. While many funding agencies mandate that data from studies they support should be freely available to the public, some journals also require data submission of research data to public databases as a precondition to publishing a research paper. Data sharing requirements by journals and granting agencies may be satisfied by use of the PubChem data archiving platform.
Automated annotations of PubChem records with PubMed articles via MeSH
PubChem generates CID-PMID associations via MeSH using depositor-provided chemical names. This is achieved by first determining which depositor-provided chemical names in PubChem are also found in MeSH. Not all chemical names in PubChem are used in this step. Chemical names provided to PubChem are passed through a sort-of crowd-sourcing filtering process, where consistency of chemical name-structure associations of depositor-provided synonyms is determined using differing levels of chemical structure sameness (e.g., potentially grouping different charge states or salt forms of the same chemical). This reduces the count of PubChem Compound records associated with a given chemical name. The resulting filtered chemical names are considered “filtered synonyms” in PubChem.
Once PubChem chemical names are matched to MeSH concepts, the MeSH concept is associated with the PubChem Compound record containing matching chemical names. Additional consistency filtering suppresses multiple MeSH concepts from being associated with the same PubChem Compound record (by taking the consensus MeSH concept for a given compound record). This helps to reduce errors but also helps to provide a consistent chemical representation for a given MeSH chemical concept.
The CID-PMID associations are generated in a final step. PubMed records that are annotated with a given MeSH chemical concept are then associated with the PubChem Compound record linked to the MeSH chemical concept. In this way (CID→Name→MeSH→PMID), linking between PubChem and PubMed is achieved.
Entrez indices used to search for records with MeSH annotations
Complete MeSH term
Retrieve compounds annotated with the MeSH term that exactly matches the query
Retrieve compounds annotated with MeSH terms that partially match the query. Note that MeSH entry terms (synonyms for the Medical Subject Heading term) are also indexed
MeSH tree node
Retrieve compounds annotated with the MeSH term that match the query and those annotated with any MeSH terms beneath the node corresponding to that MeSH term. For example, “Penicillins[MeSHTreeNode]” will retrieve records annotated with MeSH term “Penicillins”and those with MeSH terms “Oxacillin”, “Cloxacillin”, and so on, which correspond to child nodes beneath the “Penicillins” node in the MeSH tree
Retrieve compounds annotated with the MeSH terms whose description contains the query string
Retrieve compounds annotated with the Pharmacological Action term, which are a subset of MeSH terms
Retrieve compounds annotated with the Pharmacological Action term corresponding to the numeric identifier given as a query
MeSH term active
Retrieve assays in which only an active substance is annotated with the MeSH term given as a query
MeSH term tested
Retrieve assays in which any tested substance is annotated with the MeSH term given as a query
MeSH description active
Retrieve assays in which only an active substance is annotated with the MeSH terms whose descriptions have a query string
MeSH description tested
Retrieve assays in which any tested substance is annotated with the MeSH terms whose descriptions have a query string
Pharm action active
Retrieve assays in which only an active substance has the Pharmacological Action annotation given as a query
Pharm action tested
Retrieve assays in which any tested substance has the Pharmacological Action annotation given as a query
Some MeSH annotations (such as solvents, carcinogens, inhibitors, and so on) are too general to describe a specific biological function of a compound. Therefore, “Pharmacological Actions” (a subset of MeSH terms) are separately included as an Entrez index, as these annotations indicate specific biological roles of chemical concepts. The “Pharmacological Action ID” index searches for records with the Pharmacological Action annotation corresponding to a numeric identifier assigned by MeSH given as a query.
MeSH annotations of a compound can be used to annotate substance records corresponding to that compound. PubChem annotates substance records with MeSH terms for Entrez searching purposes similar to compound records. However, no attempt is made to filter chemical names or MeSH concepts for substance records, using chemical name information directly provided by individual data contributors for a given substance. In addition, the MeSH annotations of substances are not displayed on the substance record page, to avoid confusion about the provenance of displayed information.
MeSH annotations to compound records made by PubChem are used to annotate assay records testing the compounds. They are also used to generate Entrez indices that allow one to search the PubChem BioAssay database for assays that have tested compounds with a particular MeSH annotation. For example, the “MeSH Term Tested” index retrieves assay records in which any tested compound is annotated with the query MeSH term. The “MeSH Term Active” retrieves assays in which only active compounds are annotated with the query MeSH term.
Utility and discussion
Entrez links from PubChem records to PubMed articles
The associations between PubChem records and PubMed records, whether provided by data contributors or computationally derived via common MeSH annotations, are available to PubChem users as Entrez links. In general, Entrez links are crosslinks between records in different Entrez databases or within the same Entrez database. The Entrez links provide a way to discover relevant information in Entrez databases based on a user’s specific interests. For example, one can readily obtain a list of scientific articles related to a particular molecule through an Entrez link from the corresponding compound record in PubChem to associated articles in PubMed. As another example, users may access all data sets (AID) in the BioAssay database associated with a research article in PubMed. Entrez links from PubChem to PubMed records are available to users in several ways.
Entrez links on the document summary (DocSum) page
The first option “PubMed Citations” is for Entrez links derived from cross-references to PubMed articles that data contributors provided to PubChem. That is, this option will retrieve scientific articles containing information relevant to a given chemical, according to PubChem depositors. On the other hand, the third option, “PubMed (Publisher)”, is from CID-PMID associations provided by journal publishers to PubMed (not PubChem) as a part of PubMed abstract submission. Both the first and third options are similar in the sense that some organization (e.g., data contributors or journal publishers) contributed the chemical-literature associations. However, the second option “PubMed (MeSH Keyword)” corresponds to CID-PMID associations derived via MeSH annotations. This option returns articles annotated by Medline indexers with MeSH terms (chemical names). MeSH annotation can be further leveraged to find which articles have a given MeSH term as a major topic to obtain articles specifically about that chemical.
Three different types of Entrez Links also exist for substance records to PubMed articles, similar to the Compound-to-PubMed links. For the BioAssay-to-PubMed links, only one type of Entrez link to PubMed is available through the right column of the DocSum page. This returns publications associated with the BioAssay records, based on AID-PMID associations provided by data contributors to PubChem. These publications may be either source articles from which assay data are collected in curation projects, or general articles that provide background information relevant to the assay.
Entrez links on the Compound Summary page
Entrez filters from PubChem records to PubMed articles
Entrez filters used to search for records with MeSH annotations
Equivalent to “pccompound_mesh”
Equivalent to “pccompound_mesh_pharm”
Select compounds annotated with MeSH terms. Equivalent to “has_mesh”
Select compounds annotated with MeSH Pharmacological Actions. Equivalent to “has_pharm”
Select compounds that have associated full-text articles in PubMed Central
Select compounds that have depositor-provided cross-references to PubMed articles
Select compounds associated with PubMed abstracts that are annotated with common MeSH annotations
Select compounds that have cross-references to PubMed articles, provided to PubMed by publishers
Select assays that have associated full-text articles in PubMed Central
Select assays that have depositor-provided cross-references to PubMed articles
Select assays that have cross-references to the PubMed articles that contains the original bioactivity data in the assays
While the “pccompound_mesh” filter retrieves any compounds with MeSH annotations, the “pccompound_mesh_pharm” filter selects those with Pharmacological Action annotations. These filters are equivalent to the “has_mesh” and “has_pharm” filters, respectively. The “pccompound_pmc” filter allows one to choose compounds that have associated full-text articles in PubMed Central.
The Substance database also has Entrez filters that are similar to those for compound records listed in Table 4. For example, the “pcsubstance_pubmed” and “pcsubstance_pubmed_publisher” filters can be used to find substance records with cross-references to PubMed that are provided by PubChem depositors to PubChem and by publishers to PubMed, respectively.
Programmatic access to literature information in PubChem
The majority of compounds have no more than ten associated PMIDs (i.e., 95 % of CIDs with depositor-provided PMIDs and 70 % of CIDs with automated annotations via MeSH). However, some compounds are associated with many PMIDs. For example, d-glucose has as many as 130,545 depositor-provided PMIDs and 132,017 PMIDs generated via MeSH.
It is worth noting that the CID-PMID associations via MeSH tend to be limited to chemicals that are sufficiently well known to be included in MeSH. These chemicals correspond to only a small fraction of all chemicals studied in scientific articles contained in PubMed. Therefore, associations generated via MeSH may ignore specific chemicals (favoring instead a chemical class) unless they are already included in MeSH or sufficiently noteworthy to be specifically added. With that said, depositor-provided CID-PMID associations do not suffer the same limitation as MeSH and provide a greatly increased number of chemicals mentioned in the biomedical literature, as suggested in Fig. 7.
However, a caveat against depositor-provided associations is that the accuracy and usefulness of these links solely rely on individual depositors’ quality control efforts, as PubChem does not (currently) provide an independent quality control mechanism. To address this, PubChem is exploring a few possibilities. For example, one option is to process PubMed abstracts (and PubMed Central full-text papers) using text-mining software for chemical recognition (in text, tables, and figures). The resulting CID-PMID associations can be used to cross-validate the existing depositor-provided associations and to better understand the context of the chemical mention. Annotation of CID-PMID associations (e.g., location, context) may help prioritize the display of PMIDs associated to a given compound.
Literature information available in PubChem for substances, compounds and assays, as well as how this information can be accessed, was described. Individual data contributors provide PubChem with cross-references between chemical substances and PubMed articles that contain information on that substance. From these SID-PMID cross-references, PubChem generates cross-references between the corresponding compound and the PubMed articles (i.e., CID-PMID cross-references). Data contributors can also supply a list of PMIDs for scientific articles that have information relevant to a given assay record. These articles may contain various kinds of information related to the assay, including experimental protocols, assay targets, diseases associated with the targets, and known ligands that bind the targets. Of particular interest, some data contributors provide bioactivity data extracted from literature through manual curation or data mining and are an important source of bioactivity information in PubChem that complement HTS data from the now-concluded NIH Molecular Libraries Program and other HTS projects. In addition to community-provided literature information, PubChem generates Entrez links between PubChem records and PubMed articles that share the same MeSH annotation. This automated process allows PubChem users to leverage the biomedical literature and its MeSH indexing for search and analysis purposes.
Some journals, such as Nature Chemical Biology, provide PubChem with information on chemicals that appear in their newly published articles. This enables PubChem to direct users to the new articles on the journal web site, even before their abstracts become available in PubMed. In turn, the publisher can provide their readers with access to comprehensive information available in PubChem about the chemicals mentioned in a given article. This exemplifies the mutual benefit of concurrent publication of scientific articles in journals and associated data in public databases.
Literature information, both provided by depositors and derived via MeSH, can be accessed from the DocSum page of an Entrez search result, or from the Compound Summary, Substance Record, or BioAssay Record page. Users can also retrieve PubChem records associated with scientific articles, using appropriate Entrez filters. These tools allow PubChem users to more readily explore information available in literature related to PubChem records.
SK collected and analyzed the data and wrote the first manuscript, and all other authors contributed to writing the manuscript. PAT handles the database infrastructure and access methods. BAS takes care of the data submission system. BY manages the chemical name filtering process. TC, JW, and YW provided and analyzed bioassay-related data. EEB and SHB reviewed the final manuscript. All authors read and approved the final manuscript.
This work was supported by the Intramural Research Program of the National Library of Medicine, National Institutes of Health. Special thanks to PubChem team members (present and past), the Entrez infrastructure group, the MeSH group, and all PubChem data contributors without which this work would not be possible. We also thank Nancy Terry, NIH Library Editing Service, for reviewing the manuscript.
The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Agarwala R, Barrett T, Beck J, Benson DA, Bollin C, Bolton E, Bourexis D, Brister JR, Bryant SH, Canese K, Clark K, DiCuccio M, Dondoshansky I, Federhen S, Feolo M, Funk K, Geer LY, Gorelenkov V, Hoeppner M, Holmes B, Johnson M, Khotomlianski VE, Kimchi A, Kimelman M, Kitts P, Klimke W, Krasnov S, Kuznetsov A, Landrum MJ, Landsman D et al (2015) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 43:D6–D17View ArticleGoogle Scholar
- Wang YL, Suzek T, Zhang J, Wang JY, He SQ, Cheng TJ, Shoemaker BA, Gindulyte A, Bryant SH (2014) PubChem BioAssay: 2014 update. Nucleic Acids Res 42:D1075–D1082View ArticleGoogle Scholar
- Wang YL, Bolton E, Dracheva S, Karapetyan K, Shoemaker BA, Suzek TO, Wang JY, Xiao JW, Zhang J, Bryant SH (2010) An overview of the PubChem BioAssay resource. Nucleic Acids Res 38:D255–D266View ArticleGoogle Scholar
- Wang YL, Xiao JW, Suzek TO, Zhang J, Wang JY, Bryant SH (2009) PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res 37:W623–W633View ArticleGoogle Scholar
- Bolton EE, Wang Y, Thiessen PA, Bryant SH (2008) PubChem: integrated platform of small molecules and biological activities. In: Ralph AW, David CS (eds) Annual reports in computational chemistry, vol 4. Elsevier, Amsterdam, pp 217–241Google Scholar
- Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA, Wang J, Yu B, Zhang J, Bryant SH (2016) PubChem substance and compound databases. Nucleic Acids Res 44:D1202–D1213View ArticleGoogle Scholar
- What is the difference between a substance and a compound in PubChem? (2014). https://pubchemblog.ncbi.nlm.nih.gov/2014/06/19/what-is-the-difference-between-a-substance-and-a-compound-in-pubchem/. Accessed 15 April 2016
- Fact Sheet - PubMed: MEDLINE Retrieval on the World Wide Web (2014). http://www.nlm.nih.gov/pubs/factsheets/pubmed.html. Accessed 15 April 2016
- PubMed: The Bibliographic Database (2013). http://www.ncbi.nlm.nih.gov/books/NBK153385/. Accessed 15 April 2016
- PubMed Help [Internet] (2016). http://www.ncbi.nlm.nih.gov/books/NBK3827/. Accessed 15 April 2016
- Fact Sheet-MEDLINE, PubMed, and PMC (PubMed Central): How are they different? (2016). http://www.nlm.nih.gov/pubs/factsheets/dif_med_pub.html. Accessed 15 April 2016
- Fact Sheet-MEDLINE (2015) http://www.nlm.nih.gov/pubs/factsheets/medline.html. Accessed 15 April 2016
- Fact Sheet-Medical Subject Headings (MeSH) (2015) https://www.nlm.nih.gov/pubs/factsheets/mesh.html. Accessed 15 April 2016
- Medical Subject Headings. http://www.ncbi.nlm.nih.gov/mesh. Accessed 15 April 2016
- Davis AP, Grondin CJ, Lennon-Hopkins K, Saraceni-Richards C, Sciaky D, King BL, Wiegers TC, Mattingly CJ (2015) The comparative toxicogenomics database’s 10th year anniversary: update 2015. Nucleic Acids Res 43:D914–D920View ArticleGoogle Scholar
- Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SPH, Buneman OP, Davenport AP, McGrath JC, Peters JA, Spedding M, Catterall WA, Fabbro D, Davies JA (2016) NC-IUPHAR: The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res 44:D1054–D1068View ArticleGoogle Scholar
- Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu YF, Djoumbou Y, Mandal R, Aziat F, Dong E, Bouatra S, Sinelnikov I, Arndt D, Xia JG, Liu P, Yallou F, Bjorndahl T, Perez-Pineiro R, Eisner R, Allen F, Neveu V, Greiner R, Scalbert A (2013) HMDB 3.0—the human metabolome database in 2013. Nucleic Acids Res 41:D801–D807View ArticleGoogle Scholar
- Vita R, Overton JA, Greenbaum JA, Ponomarenko J, Clark JD, Cantrell JR, Wheeler DK, Gabbard JL, Hix D, Sette A, Peters B (2015) The immune epitope database (IEDB) 3.0. Nucleic Acids Res 43:D405–D412View ArticleGoogle Scholar
- Caspi R, Altman T, Billington R, Dreher K, Foerster H, Fulcher CA, Holland TA, Keseler IM, Kothari A, Kubo A, Krummenacker M, Latendresse M, Mueller LA, Ong Q, Paley S, Subhraveti P, Weaver DS, Weerasinghe D, Zhang PF, Karp PD (2014) The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res 42:D459–D471View ArticleGoogle Scholar
- Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu YF, Maciejewski A, Arndt D, Wilson M, Neveu V, Tang A, Gabriel G, Ly C, Adamjee S, Dame ZT, Han BS, Zhou Y, Wishart DS (2014) DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res 42:D1091–D1097View ArticleGoogle Scholar
- Gao JF, Ellis LBM, Wackett LP (2010) The University of Minnesota biocatalysis/biodegradation database: improving public access. Nucleic Acids Res 38:D488–D491View ArticleGoogle Scholar
- Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, Kruger FA, Light Y, Mak L, McGlinchey S, Nowotka M, Papadatos G, Santos R, Overington JP (2014) The ChEMBL bioactivity database: an update. Nucleic Acids Res 42:D1083–D1090View ArticleGoogle Scholar
- Liu ZH, Li Y, Han L, Li J, Liu J, Zhao ZX, Nie W, Liu YC, Wang RX (2015) PDB-wide collection of binding data: current status of the PDBbind database. Bioinformatics 31:405–412View ArticleGoogle Scholar
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235–242View ArticleGoogle Scholar
- Madej T, Lanczycki CJ, Zhang DC, Thiessen PA, Geer RC, Marchler-Bauer A, Bryant SH (2014) MMDB and VAST+: tracking structural similarities between macromolecular complexes. Nucleic Acids Res 42:D297–D303View ArticleGoogle Scholar
- Liu TQ, Lin YM, Wen X, Jorissen RN, Gilson MK (2007) BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res 35:D198–D201View ArticleGoogle Scholar
- Okuno Y, Tamon A, Yabuuchi H, Niijima S, Minowa Y, Tonomura K, Kunimoto R, Feng CL (2008) GLIDA: GPCR—ligand database for chemical genomics drug discovery—database and tools update. Nucleic Acids Res 36:D907–D912View ArticleGoogle Scholar
- Schuler GD, Epstein JA, Ohkawa H, Kans JA (1996) Entrez: molecular biology database and retrieval system. Methods Enzymol 266:141–162View ArticleGoogle Scholar
- McEntyre J (1998) Linking up with Entrez. Trends Genet 14:39–40View ArticleGoogle Scholar
- Entrez Programming Utilities Help. http://www.ncbi.nlm.nih.gov/books/NBK25501
- Kim S, Thiessen PA, Bolton EE, Bryant SH (2015) PUG-SOAP and PUG-REST: web services for programmatic access to chemical information in PubChem. Nucleic Acids Res 43:W605–W611View ArticleGoogle Scholar